Incyte makes $2 billion bet on bleeding disorder drug ahead of Jakafi patent cliff Incyte said on Monday it will buy Vega Therapeutics, a wholly owned subsidiary of privately held Star Therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results